Viewing Study NCT04044651


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-06-02 @ 3:04 AM
Study NCT ID: NCT04044651
Status: WITHDRAWN
Last Update Posted: 2020-01-09
First Post: 2019-07-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sponsor: Shi Ming
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HCC-S051
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View